FDA Inspection 1179507 — Apotex Inc.

Apotex Inc. — FEI 3001617666

The FDA completed an inspection of Apotex Inc. on September 14, 2022 in Richmond Hill. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Richmond Hill (Canada)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products